High-dose methotrexate for isolated central nervous system relapse in patients with testicular non-Hodgkin's lymphoma.
Four consecutive patients with testicular non-Hodgkin's lymphoma who initially achieved a complete response to treatment with standard combination therapy later developed isolated central nervous system (CNS) relapses. At the time of CNS relapse, staging evaluations were negative for lymphoma outside the nervous system in all 4 patients. These patients were treated with high-dose intravenous methotrexate alone, and a complete remission was achieved in all 4 patients.
Batchelor
T
T
Brain Tumor Center, Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA. tbatchelor@partners.org
Leahy
N
N
Kaufman
D
D
D000368:Aged; D000369:Aged, 80 and over; D001921:Brain / Q000473:pathology; D001932:Brain Neoplasms / Q000473:pathology; D016543:Central Nervous System Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D018450:Disease Progression; D018572:Disease-Free Survival; D006801:Humans; D007275:Injections, Intravenous; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000473:pathology*; D008279:Magnetic Resonance Imaging; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D012008:Recurrence; D013736:Testicular Neoplasms / Q000188:drug therapy* / Q000473:pathology*
D008727:Methotrexate